Loading stock data…
$126.55-1.55 (-1.21%)
AptarGroup, Inc.
AptarGroup, Inc. in the Healthcare sector is trading at $126.55 with a market capitalization of $7.6B. Wall Street consensus targets $162.25 (8 analysts), implying a +28.2% move over the next 12 months. The stock is currently 14% below its 52-week high of $146.91, remaining 0.2% above its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the safe zone. The Whystock Score of 85/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | — | $982.87M↑ | $962.74M↑ | $961.13M↓ | $966.01M |
| Gross Profit | — | $351.91M↑ | $338.22M↓ | $363.08M↓ | $367.01M |
| Operating Income | — | $108.58M↓ | $110.32M↓ | $139.09M↓ | $145.97M |
| Net Income | — | $72.67M↓ | $74.34M↓ | $127.93M↑ | $111.72M |
AptarGroup, Inc. designs and manufactures drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, fragrance, facial skincare, color cosmetics, personal care, home care, and food and bever...